middle.news
Rhythm Biosciences Accelerates geneType™ Integration, Unlocking New Cancer Diagnostic Horizons
9:06am on Tuesday 4th of February, 2025 AEDT
•
Healthcare
Read Story
Rhythm Biosciences Accelerates geneType™ Integration, Unlocking New Cancer Diagnostic Horizons
9:06am on Tuesday 4th of February, 2025 AEDT
Key Points
Significant portion of geneType™ integration completed ahead of 12-week schedule
Restoration of key commercial processes and partnerships with Nest Genomics and DNAnexus
Transfer of critical personnel and valuable patient clinical data secured
Full integration expected by end of February 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Rhythm Biosciences (ASX:RHY)
OPEN ARTICLE